Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort

Anja P. Husa; Jani Moilanen; Graham K. Murray; Riikka Marttila; Marianne Haapea; Irina Rannikko; Jennifer H. Barnett; Peter B. Jones; Matti Isohanni; Anne M. Remes; Hannu Koponen; Jouko Miettunen; Erika Jaaskelainen

doi:10.1016/j.psychres.2016.10.085

Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort

Anja P. Husa, Jani Moilanen, Graham K. Murray, Riikka Marttila, Marianne Haapea, Irina Rannikko, Jennifer H. Barnett, Peter B. Jones, Matti Isohanni, Anne M. Remes, Hannu Koponen, Jouko Miettunen, Erika Jaaskelainen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Psychiatry Research
Volume	247
Pages (from-to)	130-138
Number of pages	9
ISSN	0165-1781
DOIs	https://doi.org/10.1016/j.psychres.2016.10.085
Publication status	Published - Jan 2017
MoE publication type	A1 Journal article-refereed

Fields of Science

Psychosis
Cognition
Treatment
Cross-sectional
Adverse effect
FOLLOW-UP
1ST-EPISODE PSYCHOSIS
LONGITUDINAL MRI
DOSE-REDUCTION
METAANALYSIS
DEFICITS
NEUROCOGNITION
RELIABILITY
RISPERIDONE
OLANZAPINE
3124 Neurology and psychiatry

Access to Document

10.1016/j.psychres.2016.10.085

LifetimeFinal published version, 241 KBLicence: CC BY

Cite this

Husa, A. P., Moilanen, J., Murray, G. K., Marttila, R., Haapea, M., Rannikko, I., Barnett, J. H., Jones, P. B., Isohanni, M., Remes, A. M., Koponen, H., Miettunen, J., & Jaaskelainen, E. (2017). Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort. Psychiatry Research, 247, 130-138. https://doi.org/10.1016/j.psychres.2016.10.085

@article{155e570169014ecc997ec1f9d17ec2ea,

title = "Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort",

keywords = "Psychosis, Cognition, Treatment, Cross-sectional, Adverse effect, FOLLOW-UP, 1ST-EPISODE PSYCHOSIS, LONGITUDINAL MRI, DOSE-REDUCTION, METAANALYSIS, DEFICITS, NEUROCOGNITION, RELIABILITY, RISPERIDONE, OLANZAPINE, 3124 Neurology and psychiatry",

author = "Husa, {Anja P.} and Jani Moilanen and Murray, {Graham K.} and Riikka Marttila and Marianne Haapea and Irina Rannikko and Barnett, {Jennifer H.} and Jones, {Peter B.} and Matti Isohanni and Remes, {Anne M.} and Hannu Koponen and Jouko Miettunen and Erika Jaaskelainen",

year = "2017",

month = jan,

doi = "10.1016/j.psychres.2016.10.085",

language = "English",

volume = "247",

pages = "130--138",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "ELSEVIER IRELAND LTD",

}

Husa, AP, Moilanen, J, Murray, GK, Marttila, R, Haapea, M, Rannikko, I, Barnett, JH, Jones, PB, Isohanni, M, Remes, AM, Koponen, H, Miettunen, J & Jaaskelainen, E 2017, 'Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort', Psychiatry Research, vol. 247, pp. 130-138. https://doi.org/10.1016/j.psychres.2016.10.085

TY - JOUR

T1 - Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort

AU - Husa, Anja P.

AU - Moilanen, Jani

AU - Murray, Graham K.

AU - Marttila, Riikka

AU - Haapea, Marianne

AU - Rannikko, Irina

AU - Barnett, Jennifer H.

AU - Jones, Peter B.

AU - Isohanni, Matti

AU - Remes, Anne M.

AU - Koponen, Hannu

AU - Miettunen, Jouko

AU - Jaaskelainen, Erika

PY - 2017/1

Y1 - 2017/1

KW - Psychosis

KW - Cognition

KW - Treatment

KW - Cross-sectional

KW - Adverse effect

KW - FOLLOW-UP

KW - 1ST-EPISODE PSYCHOSIS

KW - LONGITUDINAL MRI

KW - DOSE-REDUCTION

KW - METAANALYSIS

KW - DEFICITS

KW - NEUROCOGNITION

KW - RELIABILITY

KW - RISPERIDONE

KW - OLANZAPINE

KW - 3124 Neurology and psychiatry

U2 - 10.1016/j.psychres.2016.10.085

DO - 10.1016/j.psychres.2016.10.085

M3 - Article

SN - 0165-1781

VL - 247

SP - 130

EP - 138

JO - Psychiatry Research

JF - Psychiatry Research

ER -